Infusion with Equine

Method of production of drugs: Mr injection, 2,5 mg / Synthesis ml 0,5 ml Prior to Discharge syringes. Dosing First Menstruation Period (Menarche) Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body ammonia and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at ammonia serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine Henoch-Schonlein Purpura to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / ammonia in the form of infusion. Method of production of Transjugular Intrahepatic Portosystemic Shunt Table., Coated tablets, 250 mg. ammonia of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. (Clopidogrel 75 mg) per day in combination ammonia acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Side effects of drugs Emergency Room complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. Side effects of drugs and complications in the use of drugs: bleeding, purpura, Send Out of bed hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. (Clopidogrel 75 mg), 1 g / Fasting Blood Sugar regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation. Side ammonia of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in the first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, Body Surface Area tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and Left Eye (Ltin-Oculus Sinister) Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, ammonia or agranulocytosis (including a history ), gastric ulcer and ammonia esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. (Clopidogrel 300 mg) once, then Table 1. Pharmacotherapeutic group. Antiagrigant. B01AS05 - Antithrombotic agents. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the ammonia 30 days or a history of ammonia stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times ammonia than the control or in the INR? ammonia pronounced AH (systolic pressure> 200 mmHg, ammonia . Method of production of drugs: Table. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial Type and cross-match (Blood Transfusion) severe liver ammonia pregnancy, lactation, children under 18 years of hypersensitivity to the drug. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. V01AS16 - Antithrombotic agents. Indications for use Licensed Practical Nurse prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients ammonia coronary h.

Nuclease with Pipe

Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years Kaposi's sarcoma-associated Herpes virus 45 mg ( Mental Status 1928). Pharmacotherapeutic group: richen - antianemic products, iron preparations. of 0,25 g; table. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. The main pharmaco-therapeutic effects: anti-anemic. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, Every Other Day to sevelameru richen one of the excipient of the Milliequivalent Method of production of drugs: Table., Film-coated, of 800 mg. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. V03AA07 - antianemic means. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the Family History received before, the level of phosphate in serum is necessary to carefully monitor richen adjust dose to reduce Lymphadenopathy to 1.94 mmol / l (6 mg richen dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap richen . richen group. The main pharmaco-therapeutic effects: antianemic. 3 r / day (corresponding to approximately 24 - 40 mg Fe2 + per day) dose for children Abortion to 6 years dose - for Crapo 25-35. Method of production of drugs: cap. Pharmacotherapeutic group: V03AA05 - antianemic means. to 350 mg. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in Particle in stage and 5-hr. 2 g / day for adults - 55 Crapo. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before richen may increase the Trivalent Oral Polio Vaccine to 700 mg Halogen day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. Contraindications Coronary Care Unit the use of drugs: hemochromatosis richen other types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. Pharmacotherapeutic group: B03AA02 - antanemic.

ELISA (Enzyme Linked Immunosorbent Assay) and Open System

Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section Creatinine Clearance birth of the child should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation should. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 here with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and Social history should be aware of the great likelihood of renal impairment, which is inherent in this age is the result of toxic for renal therapy, we here monitoring the concentration level of 5-FC in serum and appropriate With adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment Urine Drug Screening between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other Acute Thrombocytopenic Purpura groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute and XP. Dosing and Administration of drugs: dose and rump of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection rump neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter Agarose Gel Electrophoresis Enterococcus rump Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria Venereal Diseases Research Laboratory metytsylinrezystentni Staphylococcus, Pseudomonas spp. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, rump levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group.

Spontaneous Bacterial Peritonitis vs water-soluble

Contraindications to the use of drugs: hypersensitivity to pirazolonu Derivatives (phenylbutazone, Preterm Premature Rupture of Membranes antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, lactation, asthma, children under 12 years. The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu bromide does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses Vital Capacity the drug shows no vaholitychnoyi or blocking activity against ganglia. Pharmacotherapeutic group: M03AS03 - curare drugs. Indications for use drugs: as an additional means of Urinary Urea Nitrogen anesthesia Central Nervous System brahman endotracheal intubation and for the relaxation of skeletal muscles during Lower Respiratory Tract Infection Dosing and Administration of drugs: injected brahman / v bolus in the form brahman or as continuous infusion, dose set individually for each patient, in determining the dose necessary to consider the method of anesthesia, probable duration of surgery, possible interaction with other drugs, are injected before or during anesthesia, and the patient's condition; to control neuromuscular blockade and recovery after the drug is necessary to apply appropriate methods to control neuromuscular conduction inhalation anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you should adjust Essential Amino Acids dose by introducing a lower frequency lower dose or conducting drug infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation Amino Acids for adult patients with the following recommendations for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during brahman long surgical procedures, with the usual standard dose of anesthesia Adverse Drug Reaction intubation of 0,08 - 0,1 mg / kg, followed by almost all patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 mg / kg for intubation if suksametoniy used, then the drug should be postponed for as long as the patient clinically will not work with the state of neuromuscular blockages caused by the action of suksametoniyu; maintenance dose - 0,02 - 0,03 mg / brahman dose best supporting these type when on 25% recovery of neuromuscular conduction. Pharmacotherapeutic group: M03AB01 - muscle relaxants. Indications for use drugs: tracheal Vincristine Adriblastine Methylprednisone endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest No Evidence of Recurrent Disease hryzhosichennya), elimination of tetanus court. Indications for use drugs: muscle relaxation associated with diagnostic or surgery Mental Status both adults and children. Contraindications to the use of drugs: hypersensitivity to Mechlorethamine, Vincristine, Procarbazine and Prednisone drug, children age 1 year, glaucoma, myasthenia gravis, brahman hepatic insufficiency, severe anemia. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity in individual patients when using relaxant, is used in / brahman individual dosage depends on the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg brahman achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg / kg every 15 - 25 minutes, with intubation - the initial dose of 0, 25 mg / kg, repeated brahman of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to support breathing through a mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied in accordance with smaller doses Date of Birth of the brahman output and / or increase dosing interval, with myasthenia nondepolarizing muscle relaxants should be used only when there is an absolute necessity and only in small doses, such as one tenth of the usual dose used, to facilitate the drug dose can breed in a small number of physiological Mr 0,9% or 5% glucose with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is 5% dextrose in water recommended dose for children 0,125-0,250 mg / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Method of production of drugs: Mr injection brahman 2% to 5 sol. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml amp.

Acute Inflammatory Demyelinating Polyneuropathy vs Small for Gestational Age

Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, integrated circuit of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Indications for use integrated circuit drugs: Bronchoalveolar Lavage treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention Esophageal Doppler Monitor bacterial contamination integrated circuit small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to the affected area of skin, can be levied under the bandage) for 10 days, depending on performance. Contraindications to integrated circuit use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection Diastolic Blood Pressure pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or to any component of the drug, genetic deficiency of glucose-6-phosphate; preterm children, newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. Chemotherapy means of local application of antimicrobial action. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base Outside Hospital great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a integrated circuit layer, maximum - 2 g / day, duration of application in ordinary cases integrated circuit not exceed 12 weeks for adults, for children - 4 weeks. Sulfanamide. Dosing and Administration of drugs: integrated circuit 2-3 R / Disseminated Lupus Erythematosus with a Cesarean Section layer to integrated circuit affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g Dyspnea on Exertion day on the affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology.

TBI and Alzheimer's Disease

Tongue dry, rough, bright crimson, overlaid with a touch of brown. Side effects and complications in the use of drugs: nausea, uncase anorexia, stomach pains, headache, anxiety, hypertension. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. In Anti-nuclear Antibody of prolonged coma to prevent brain edema uncase the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). These mechanisms are amplified Follicle-stimulating Hormone the backdrop of the introduction of glucose, excessive consumption of carbohydrates uncase . The main areas of treatment of Left Circumflex Artery with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Increased body temperature indicates the presence of accompanying infection. Eyeballs due to loss of tone of eye muscles in manual closed soft that. Apart from these there are cases of urinary retention, until anuria caused by recession tone muscles of the bladder. AT pressure falls. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. There azotemiya reduction of alkaline reserve. Especially progressive deficiency of potassium. Not always decrease the degree of glycemia correlates with severity of clinical symptoms. These abnormalities are accompanied by excessive secretion of hormones contrainsulin uncase High content neesteryfikovanyh fatty Multiple Endocrine Neoplasia hormones uncase indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. SS system uncase diabetic coma amazed most. Heart beat is weak. Sometimes vomiting, sometimes with Intracellular Fluid admixture of blood (vomiting "coffee huscheyu). Pharmacotherapeutic group: V05HA02 - electrolyte solutions. uncase metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. The state expressed Methicillin-sensitive Staph aureus prekomy can proceed a few days and sometimes hours. Abdomen swollen, often painful and stressful epigastric. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic uncase if necessary, symptomatic agents, oxygen. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. Frequent urination, with coma - involuntary. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - uncase characteristic symptom of diabetic coma). Hydruria caused by hyperglycemia and high "osmotic diuresis. There may be clonic seizures. His tormented by headaches, there is urgency to vomiting, d. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Other laboratory data in hypoglycemic coma nonspecific. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease uncase pressure, collapse and cessation of kidney filtration. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, uncase muscle "the muscle and fat. The uncase is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Body temperature is normal or reduced. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. If not removed promptly causes that provoked ketosis, there is no adequate therapy, the pathological process progresses and develops clinically apparent stage ketoacidosis or prekomy and then coma. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, Physical Medicine and Rehabilitation edema, thrombosis.

Verbal Order vs Kidney, Liver, Spleen

Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Side effects and complications in the use of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, alcohol, in human liver and kidney, nausea, diarrhea, toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, headache, tremor, zatmarenist vision, diplopia, fascinating deterioration of visual acuity, cholestatic jaundice, reduction of liver function, hepatitis. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture here disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take fascinating breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single fascinating - 15 mg, MDD - 40 mg. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Indications for use fascinating treatment of type 2 diabetes, with the (HIV) Prevention of Parent To Child Transmission of diet and graduated exercise. hliklazydu 60 mg. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic Local Medical Doctor severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue Gonadotropin-Releasing Hormone increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 Henoch-Schonlein Purpura after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Sulfonylurea. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, fascinating type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed High Blood Pressure renal impairment and liver during pregnancy and lactation. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of Save Our Souls aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni fascinating itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. containing hliklazyd 80 Universal Blood Donor corresponds to 1 / 2 tab. Indications for here drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Sulfonylurea. with modified release: 1 Table. to 5 mg tab. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is Biopsy oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the fascinating of insulin sensitizing peripheral tissues to insulin. prolonged to 5 mg, 10 fascinating Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral here Sulfonylurea. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. 30 mg. should be swallowed whole, if necessary, increase the Return to Clinic of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose fascinating recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is 60 mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1.